Enalare Therapeutics: Funding, Investors & Team (Oct 2026)
Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical organization devoted to creating and commercializing novel treatments for patients experiencing intense respiratory and basic consideration conditions including respiratory melancholy brought about by drug glut, post-medical procedure, and microorganisms.
Enalare Therapeutics has raised $11.0M across 5 funding rounds on record, the most recent an undisclosed round announced in Sep 2024.
Enalare Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2024.
Enalare Therapeutics Funding Rounds
2 of 5 rounds were announced without a disclosed amount and are excluded from the total.
Enalare Therapeutics raised $10.0M in a Seed announced in Feb 2021.
1 years later, a Debt Financing of $1.0M was announced in Feb 2022.
5 months later, a Grant was announced in Jul 2022 with no disclosed amount.
7 months later, an undisclosed round of $30k was announced in Feb 2023.
1.6 years later, an undisclosed round was announced in Sep 2024 with no disclosed amount.
Enalare Therapeutics Founders and Leadership Team
Contact details for the Enalare Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Enalare Therapeutics Funding Compared to Other Biotechnology Startups
Funded Startups Like Enalare Therapeutics in Biotechnology and Naples
Companies Similar to Enalare Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Enalare Therapeutics Funding FAQs
What does Enalare Therapeutics do?
Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical organization devoted to creating and commercializing novel treatments for patients experiencing intense respiratory and basic consideration conditions including respiratory melancholy brought about by drug glut, post-medical procedure, and microorganisms.
How much funding has Enalare Therapeutics raised?
Enalare Therapeutics has raised $11.0M across 5 rounds on record.
When did Enalare Therapeutics last raise funding?
Enalare Therapeutics' most recent funding round on record was announced in Sep 2024. The amount was not disclosed.
Who is the CEO of Enalare Therapeutics?
Herm Cukier is listed as CEO at Enalare Therapeutics.
Where is Enalare Therapeutics headquartered?
Enalare Therapeutics is based in Naples, Florida, United States.
How many employees does Enalare Therapeutics have?
Enalare Therapeutics is in the 1-10 employee band.
About FundedIQ's Enalare Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Enalare Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.